Panacea Life Sciences Holdings, Inc. (PLSH) is holding company structured to develop and facilitate manufacturing, research, product development and distribution in the high-growth, natural human and animal health & wellness market segment. Its subsidiary, Panacea Life Sciences, Inc. (PLS) is a woman-founded and led company dedicated to manufacturing, distribution, research and production of the highest-quality nutraceutical, cannabinoid, mushroom, kratom and other natural, plant-based ingredients and products. PLS operates out of a 51,000 square foot, state-of-the-art, cGMP facility in Golden Colorado. If you would like more information, please visit www.panacealife.com
Company profile
Ticker
PLSH, EXDID
Exchange
Website
CEO
Philip J. Young
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Exactus, Inc., Solid Solar Energy, Inc., Spiral Energy Tech., Inc.
SEC CIK
PLSH stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
1 Apr 24
8-K
Entry into a Material Definitive Agreement
7 Mar 24
8-K
Entry into a Material Definitive Agreement
5 Feb 24
8-K/A
Report of Independent Registered Public Accounting Firm
8 Dec 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Entry into a Material Definitive Agreement
5 Oct 23
8-K
Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise
2 Oct 23
10-Q
2023 Q2
Quarterly report
15 Aug 23
NT 10-Q
Notice of late quarterly filing
15 Aug 23
8-K
Entry into a Material Definitive Agreement
10 Jul 23
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.50 k | 1.50 k | 1.50 k | 1.50 k | 1.50 k | 1.50 k |
Cash burn (monthly) | 2.23 k | 2.94 k | 717.03 k | 625.94 k | 242.96 k | 170.75 k |
Cash used (since last report) | 15.34 k | 20.22 k | 4.93 mm | 4.30 mm | 1.67 mm | 1.17 mm |
Cash remaining | -13.85 k | -18.73 k | -4.93 mm | -4.30 mm | -1.67 mm | -1.17 mm |
Runway (months of cash) | -6.2 | -6.4 | -6.9 | -6.9 | -6.9 | -6.9 |
Institutional ownership, Q2 2022
5.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 4.42 mm |
Total shares | 1.04 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Kesner Harvey J | 1.04 mm | $487.00 k |
Castleview Partners | 16.00 | $3.94 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Sep 23 | Leslie Buttorff | Common Stock | Buy | Acquire P | No | No | 0.2365 | 20,000 | 4.73 k | 1,533,949 |
9 Jun 23 | Leslie Buttorff | Common Stock | Buy | Acquire P | No | No | 0.4325 | 3,000 | 1.30 k | 1,513,949 |
2 Jun 23 | Leslie Buttorff | Common Stock | Grant | Acquire A | No | No | 0.5 | 760,000 | 380.00 k | 1,510,949 |
23 May 23 | Leslie Buttorff | Common Stock | Buy | Acquire P | No | No | 0.498 | 500 | 249.00 | 751,449 |
19 May 23 | Leslie Buttorff | Common Stock | Buy | Acquire P | No | No | 0.52 | 1,500 | 780.00 | 750,949 |
19 May 23 | Leslie Buttorff | Common Stock | Buy | Acquire P | No | No | 0.51 | 4,500 | 2.30 k | 746,449 |
9 May 23 | Leslie Buttorff | Common Stock | Buy | Acquire P | No | No | 0.377 | 2,300 | 867.10 | 741,949 |
8 May 23 | Leslie Buttorff | Common Stock | Buy | Acquire P | No | No | 0.43 | 1,500 | 645.00 | 739,649 |
5 May 23 | Leslie Buttorff | Common Stock | Buy | Acquire P | No | No | 0.49 | 11,500 | 5.64 k | 738,149 |
26 Apr 23 | Leslie Buttorff | Common Stock | Buy | Acquire P | No | No | 0.3976 | 5,500 | 2.19 k | 726,649 |